Can a phone app help curb heavy drinking? new trial tests Home-Based care
NCT ID NCT05747703
First seen Feb 22, 2026 · Last updated Jun 22, 2026 · Updated 16 times
Summary
This study tests a telehealth program called Ria for people with alcohol use disorder. Participants receive medication, coaching, educational videos, and a Bluetooth breathalyzer to track drinking. The goal is to see if this approach helps reduce heavy drinking more than simply waiting for treatment. 135 adults are taking part over three months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford University
Stanford, California, 94305, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ria Treatment Platform (medication, coaching, education, and Bluetooth breathalyzer)
What this could lead to
If it works, this could provide a convenient, home-based option to help people cut back on heavy drinking and manage alcohol use disorder.
What could go wrong
This is a small, early-stage trial with only 135 people and a short 3-month follow-up. The waitlist control design may limit how well the results apply to real-world settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.